Last reviewed · How we verify
Excess subcutaneous fat
Approved treatments
- Kybella · AbbVie
Kybella works by targeting and destroying excess fat cells through a process that involves disrupting the cell membrane. - Kybella · Massachusetts General Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Excess subcutaneous fat patent landscape — cliff calendar, originator estates, attackable patents
- Excess subcutaneous fat treatment landscape brief
- Excess subcutaneous fat treatment updates RSS
Frequently asked questions about Excess subcutaneous fat
What drugs treat Excess subcutaneous fat?
Tracked treatments include Kybella.
What is the treatment for Excess subcutaneous fat?
Standard treatment for Excess subcutaneous fat includes Kybella. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Excess subcutaneous fat patent cliff · Excess subcutaneous fat CI report
- Treatment: Kybella · AbbVie
- Treatment: Kybella · Massachusetts General Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing